Bruce Booth is a partner at Atlas Venture, specializing in early-stage biotech investments with a focus on transformative therapeutics. They served as a board director for multiple companies, including Zafgen Incorporated and Magenta Therapeutics, from 2006 to 2023. Currently, Bruce holds several chairperson roles at companies such as AVROBIO, HotSpot Therapeutics, and Kymera Therapeutics. They earned a B.S. in Biochemistry, summa cum laude, from Penn State University and a D.Phil. in Immunology from the University of Oxford.
This person is not in the org chart
This person is not in any teams
This person is not in any offices